Showing results (1-10 of 199) with videos related to
Sort By:
Pageof 20
Journal of Clinical Medicine Research|June 22, 2012
The Underlying Mechanisms for Olanzapine-induced HypertriglyceridemiaHiroki Adachi, Hidekatsu Yanai, Yuji HirowatariGHM Open|March 27, 2025
Association of atherogenic serum lipids and platelet activation with changes in arterial stiffness in patients with type 2 diabetesYuji Hirowatari, Hidekatsu YanaiGlobal Health & Medicine|December 17, 2020
Diabetic dyslipidemia: evaluation and mechanismHidekatsu Yanai, Yuji Hirowatari, Hiroshi YoshidaJournal of Clinical Medicine Research|September 16, 2017
The Low-Dose (7.5 mg/day) Pioglitazone TherapyHidekatsu Yanai, Hiroki AdachiAnnals of Clinical Biochemistry|May 16, 2023
Measurement of cholesterol levels of lipoprotein subclasses in human serum using anion-exchange high-performance liquid chromatography with a linear concentration gradient of sodium perchlorateRiku Ito, Daisuke Manita, Hidekatsu Yanai, et al.Cardiology Research|November 21, 2022
Chronic Kidney Disease Stage G4 in a Diabetic Patient Improved by Multi-Disciplinary Treatments Based Upon Literature Search for Therapeutic EvidenceHidekatsu Yanai, Naoki Yamaguchi, Hiroki AdachiGastroenterology Research|September 11, 2023
A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With HypertriglyceridemiaHisayuki Katsuyama, Hidekatsu Yanai, Hiroki Adachi, et al.International Journal of Molecular Sciences|November 11, 2022
Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease RiskHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.Cardiology Research|March 10, 2023
Glucagon-Like Peptide 1 Receptor Agonists Versus Sodium-Glucose Cotransporter 2 Inhibitors for Atherosclerotic Cardiovascular Disease in Patients With Type 2 DiabetesHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.Journal of Clinical Medicine Research|May 1, 2018
Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin TherapyMariko Hakoshima, Hidekatsu Yanai, Kouki Kakuta, et al.Pageof 20